NCT02386761View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Single Ascending Dose (SAD)

DRUG

Multiple Ascending Dose (MAD)

Trial Locations (1)

NG116JS

Quotient Clinical, Nottingham

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02386761 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 | Biotech Hunter | Biotech Hunter